1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Hinds, M.G. Zhang, W. Anderluh, G. Hansen, P.E. Norton, R.S. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK J.Mol.Biol. JMOBAK 0070 0022-2836 315 1219 1229 10.1006/jmbi.2001.5321 11827489 Solution structure of the eukaryotic pore-forming cytolysin equinatoxin II: implications for pore formation. 2002 NE J.Biomol.NMR JBNME9 0800 0925-2738 18 281 282 10.1023/A:1026793926271 Sequence-specific resonance assignments of the potent cytolysin equinatoxin II 2000 10.2210/pdb1kd6/pdb pdb_00001kd6 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 19859.453 EQUINATOXIN II 1 man polymer EqtII, Tenebrosin C no no SADVAGAVIDGASLSFDILKTVLEALGNVKRKIAVGVDNESGKTWTALNTYFRSGTSDIVLPHKVPHGKALLYNGQKDRG PVATGAVGVLAYLMSDGNTLAVLFSVPYDYNWYSNWWNVRIYKGKRRADQRMYEELYYNLSPFRGDNGWHTRNLGYGLKS RGFMNSSGHAILEIHVTKA SADVAGAVIDGASLSFDILKTVLEALGNVKRKIAVGVDNESGKTWTALNTYFRSGTSDIVLPHKVPHGKALLYNGQKDRG PVATGAVGVLAYLMSDGNTLAVLFSVPYDYNWYSNWWNVRIYKGKRRADQRMYEELYYNLSPFRGDNGWHTRNLGYGLKS RGFMNSSGHAILEIHVTKA A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Actinia Escherichia Escherichia coli sample 6106 Actinia equina 469008 Escherichia coli BL21(DE3) BL21(DE3) PLASMID pAG2.1 database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2002-02-13 1 1 2008-04-27 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name SEQUENCE THERE ARE TWO NATURALLY OCCURING SEQUENCE VARIANTS P116D AND T212S FOR EQUINATOXIN II P116D VARIANT OCCURS IN 50% OF MOLECULES FROM ACTINIA EQUINA AND THE T212S VARIANT IN ACTINA TENEBROSA. RCSB Y RCSB 2001-11-12 REL The structure was determined using triple resonance spectroscopy structures with acceptable covalent geometry,structures with the least restraint violations 250 20 3D_13C-separated_NOESY 3D_15N-separated_NOESY HNHA NOESY 3.9 ambient 303 K The structure is based on 3161 total restraints including 167 angle constraints, 42 hydrogen bonds, 534 sequential, 972 short range and 1346 long range distance constraints. torsion angle dyanamics distance geometry simulated annealing 1 closest to the average 1mM 13C, 15N Equinatoxin II pH 3.9 90% H2O, 10% H2O 1mM 15N Equinatoxin II pH 3.9 90% H2O, 10% H2O 1mM unlabelled Equinatoxin II pH 3.9 90% H2O, 10% H2O Varian Associates collection VNMR 6 Bruker AG processing XwinNMR 2.6 Bartels, C., Xia, T.H., Guntert, P., Wuthrich K. J Biomol NMR. 1995, 6, 1-10. data analysis XEASY 1.3.13 Guntert, P., Mumenthaler, C., Wuthrich, K.J. Mol. Biol. 1997, 273, 283-298. structure solution DYANA 1.5 Brunger, A.T., Adams, P.D., Clore, G.M., Delano, W.L., Gros, P., Grosse-Kunstleve, R.W., Jiang, J.S., Kuszewski, J., Nilges, M., Pannu, N.S, Read, R.J., Rice, L.M., Simonson, T., Warren, G.L. Acta Crystallogr. D Biol. Crystallogr. 1998, 54, 905-921. refinement CNS 1.0 600 Varian INOVA 750 Varian INOVA 800 Varian INOVA 600 Bruker DRX SER 1 n 1 SER 1 A ALA 2 n 2 ALA 2 A ASP 3 n 3 ASP 3 A VAL 4 n 4 VAL 4 A ALA 5 n 5 ALA 5 A GLY 6 n 6 GLY 6 A ALA 7 n 7 ALA 7 A VAL 8 n 8 VAL 8 A ILE 9 n 9 ILE 9 A ASP 10 n 10 ASP 10 A GLY 11 n 11 GLY 11 A ALA 12 n 12 ALA 12 A SER 13 n 13 SER 13 A LEU 14 n 14 LEU 14 A SER 15 n 15 SER 15 A PHE 16 n 16 PHE 16 A ASP 17 n 17 ASP 17 A ILE 18 n 18 ILE 18 A LEU 19 n 19 LEU 19 A LYS 20 n 20 LYS 20 A THR 21 n 21 THR 21 A VAL 22 n 22 VAL 22 A LEU 23 n 23 LEU 23 A GLU 24 n 24 GLU 24 A ALA 25 n 25 ALA 25 A LEU 26 n 26 LEU 26 A GLY 27 n 27 GLY 27 A ASN 28 n 28 ASN 28 A VAL 29 n 29 VAL 29 A LYS 30 n 30 LYS 30 A ARG 31 n 31 ARG 31 A LYS 32 n 32 LYS 32 A ILE 33 n 33 ILE 33 A ALA 34 n 34 ALA 34 A VAL 35 n 35 VAL 35 A GLY 36 n 36 GLY 36 A VAL 37 n 37 VAL 37 A ASP 38 n 38 ASP 38 A ASN 39 n 39 ASN 39 A GLU 40 n 40 GLU 40 A SER 41 n 41 SER 41 A GLY 42 n 42 GLY 42 A LYS 43 n 43 LYS 43 A THR 44 n 44 THR 44 A TRP 45 n 45 TRP 45 A THR 46 n 46 THR 46 A ALA 47 n 47 ALA 47 A LEU 48 n 48 LEU 48 A ASN 49 n 49 ASN 49 A THR 50 n 50 THR 50 A TYR 51 n 51 TYR 51 A PHE 52 n 52 PHE 52 A ARG 53 n 53 ARG 53 A SER 54 n 54 SER 54 A GLY 55 n 55 GLY 55 A THR 56 n 56 THR 56 A SER 57 n 57 SER 57 A ASP 58 n 58 ASP 58 A ILE 59 n 59 ILE 59 A VAL 60 n 60 VAL 60 A LEU 61 n 61 LEU 61 A PRO 62 n 62 PRO 62 A HIS 63 n 63 HIS 63 A LYS 64 n 64 LYS 64 A VAL 65 n 65 VAL 65 A PRO 66 n 66 PRO 66 A HIS 67 n 67 HIS 67 A GLY 68 n 68 GLY 68 A LYS 69 n 69 LYS 69 A ALA 70 n 70 ALA 70 A LEU 71 n 71 LEU 71 A LEU 72 n 72 LEU 72 A TYR 73 n 73 TYR 73 A ASN 74 n 74 ASN 74 A GLY 75 n 75 GLY 75 A GLN 76 n 76 GLN 76 A LYS 77 n 77 LYS 77 A ASP 78 n 78 ASP 78 A ARG 79 n 79 ARG 79 A GLY 80 n 80 GLY 80 A PRO 81 n 81 PRO 81 A VAL 82 n 82 VAL 82 A ALA 83 n 83 ALA 83 A THR 84 n 84 THR 84 A GLY 85 n 85 GLY 85 A ALA 86 n 86 ALA 86 A VAL 87 n 87 VAL 87 A GLY 88 n 88 GLY 88 A VAL 89 n 89 VAL 89 A LEU 90 n 90 LEU 90 A ALA 91 n 91 ALA 91 A TYR 92 n 92 TYR 92 A LEU 93 n 93 LEU 93 A MET 94 n 94 MET 94 A SER 95 n 95 SER 95 A ASP 96 n 96 ASP 96 A GLY 97 n 97 GLY 97 A ASN 98 n 98 ASN 98 A THR 99 n 99 THR 99 A LEU 100 n 100 LEU 100 A ALA 101 n 101 ALA 101 A VAL 102 n 102 VAL 102 A LEU 103 n 103 LEU 103 A PHE 104 n 104 PHE 104 A SER 105 n 105 SER 105 A VAL 106 n 106 VAL 106 A PRO 107 n 107 PRO 107 A TYR 108 n 108 TYR 108 A ASP 109 n 109 ASP 109 A TYR 110 n 110 TYR 110 A ASN 111 n 111 ASN 111 A TRP 112 n 112 TRP 112 A TYR 113 n 113 TYR 113 A SER 114 n 114 SER 114 A ASN 115 n 115 ASN 115 A TRP 116 n 116 TRP 116 A TRP 117 n 117 TRP 117 A ASN 118 n 118 ASN 118 A VAL 119 n 119 VAL 119 A ARG 120 n 120 ARG 120 A ILE 121 n 121 ILE 121 A TYR 122 n 122 TYR 122 A LYS 123 n 123 LYS 123 A GLY 124 n 124 GLY 124 A LYS 125 n 125 LYS 125 A ARG 126 n 126 ARG 126 A ARG 127 n 127 ARG 127 A ALA 128 n 128 ALA 128 A ASP 129 n 129 ASP 129 A GLN 130 n 130 GLN 130 A ARG 131 n 131 ARG 131 A MET 132 n 132 MET 132 A TYR 133 n 133 TYR 133 A GLU 134 n 134 GLU 134 A GLU 135 n 135 GLU 135 A LEU 136 n 136 LEU 136 A TYR 137 n 137 TYR 137 A TYR 138 n 138 TYR 138 A ASN 139 n 139 ASN 139 A LEU 140 n 140 LEU 140 A SER 141 n 141 SER 141 A PRO 142 n 142 PRO 142 A PHE 143 n 143 PHE 143 A ARG 144 n 144 ARG 144 A GLY 145 n 145 GLY 145 A ASP 146 n 146 ASP 146 A ASN 147 n 147 ASN 147 A GLY 148 n 148 GLY 148 A TRP 149 n 149 TRP 149 A HIS 150 n 150 HIS 150 A THR 151 n 151 THR 151 A ARG 152 n 152 ARG 152 A ASN 153 n 153 ASN 153 A LEU 154 n 154 LEU 154 A GLY 155 n 155 GLY 155 A TYR 156 n 156 TYR 156 A GLY 157 n 157 GLY 157 A LEU 158 n 158 LEU 158 A LYS 159 n 159 LYS 159 A SER 160 n 160 SER 160 A ARG 161 n 161 ARG 161 A GLY 162 n 162 GLY 162 A PHE 163 n 163 PHE 163 A MET 164 n 164 MET 164 A ASN 165 n 165 ASN 165 A SER 166 n 166 SER 166 A SER 167 n 167 SER 167 A GLY 168 n 168 GLY 168 A HIS 169 n 169 HIS 169 A ALA 170 n 170 ALA 170 A ILE 171 n 171 ILE 171 A LEU 172 n 172 LEU 172 A GLU 173 n 173 GLU 173 A ILE 174 n 174 ILE 174 A HIS 175 n 175 HIS 175 A VAL 176 n 176 VAL 176 A THR 177 n 177 THR 177 A LYS 178 n 178 LYS 178 A ALA 179 n 179 ALA 179 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O TYR 73 A O TYR 73 A N VAL 35 A N VAL 35 A N ALA 34 A N ALA 34 A O ALA 170 A O ALA 170 A O THR 177 A O THR 177 A N LYS 159 A N LYS 159 A O SER 160 A O SER 160 A N ARG 152 A N ARG 152 A N THR 46 A N THR 46 A O LEU 93 A O LEU 93 A N GLY 88 A N GLY 88 A O PHE 104 A O PHE 104 A N THR 99 A N THR 99 A O TYR 122 A O TYR 122 A N TRP 117 A N TRP 117 A O PHE 143 A O PHE 143 2 A A HG3 HA LYS ALA 159 179 1.26 2 A A HA HG3 ALA MET 128 132 1.27 2 A A HD12 HB3 LEU HIS 23 169 1.30 2 A A HD23 HB3 LEU ALA 14 70 1.32 2 A A OD1 H ASP GLN 129 130 1.56 3 A A HA HB2 TRP PHE 149 163 1.33 3 A A HZ1 O LYS ALA 159 179 1.59 4 A A HE2 HG PHE LEU 104 172 1.13 4 A A HE3 HA2 LYS GLY 77 85 1.20 4 A A HZ1 HD1 LYS TYR 77 108 1.24 4 A A HA HB2 TRP PHE 149 163 1.28 4 A A HG22 HE3 VAL MET 89 132 1.31 4 A A O H SER VAL 54 87 1.57 5 A A HG23 H VAL LYS 29 30 1.28 5 A A HD13 HZ2 LEU LYS 26 32 1.28 6 A A HZ2 HD2 TRP HIS 117 150 1.26 6 A A H O THR TYR 99 122 1.59 8 A A O H TYR TYR 108 110 1.59 9 A A HZ2 HE2 TRP HIS 117 150 1.33 9 A A HZ2 OXT LYS ALA 159 179 1.56 10 A A HB3 HB3 ALA LEU 47 61 1.27 11 A A HB2 H PRO HIS 66 67 1.34 13 A A HD1 H PHE MET 163 164 1.18 13 A A O HG TYR SER 113 114 1.58 14 A A HZ2 HE2 TRP HIS 117 150 1.27 14 A A HG21 HG VAL LEU 89 103 1.27 14 A A HZ2 OXT LYS ALA 159 179 1.59 15 A A HE3 HA LYS ALA 77 83 1.34 15 A A HD11 HD3 LEU LYS 26 32 1.34 15 A A HZ2 OXT LYS ALA 159 179 1.59 16 A A HZ2 HE2 TRP HIS 117 150 1.08 16 A A HZ3 HA2 LYS GLY 77 85 1.31 16 A A OD1 H ASP GLN 129 130 1.60 17 A A HD13 HA LEU LYS 158 178 1.27 17 A A HD21 HG11 ASN VAL 39 65 1.34 19 A A HZ2 HE2 TRP HIS 117 150 1.19 19 A A HB2 H PRO HIS 66 67 1.31 19 A A HA3 HA GLY ILE 162 174 1.35 20 A A HG22 HG VAL LEU 89 103 1.29 1 A ALA 2 -146.51 -56.61 1 A ALA 5 -109.02 44.86 1 A ALA 7 -97.04 44.87 1 A ALA 12 -154.66 -32.95 1 A ALA 25 -90.18 34.41 1 A ASN 28 -78.44 43.66 1 A SER 54 -133.98 -70.89 1 A THR 56 -165.61 -167.46 1 A SER 57 -159.96 -53.53 1 A HIS 63 -119.48 51.29 1 A GLN 76 -145.19 46.60 1 A LYS 77 52.64 175.81 1 A ARG 79 72.86 -46.93 1 A PRO 81 -71.53 -142.10 1 A SER 95 -167.35 -100.34 1 A TYR 108 -84.26 40.12 1 A ASN 111 -160.76 -131.61 1 A ARG 126 69.99 129.32 1 A ASP 129 -161.19 -159.42 1 A GLU 135 56.80 -56.51 1 A TYR 137 -78.34 40.46 1 A SER 141 -153.38 76.94 1 A ASN 147 -47.19 92.17 1 A ARG 152 -171.50 144.16 1 A PHE 163 -175.15 -174.58 1 A SER 166 -82.36 -121.50 1 A GLU 173 -116.40 75.85 2 A ALA 5 70.00 131.72 2 A ALA 12 -154.87 -38.75 2 A LEU 26 -80.78 44.90 2 A ASN 28 -135.09 -45.84 2 A SER 41 -92.52 -76.93 2 A LEU 48 -120.45 -57.73 2 A THR 56 -171.06 143.18 2 A ASP 58 -176.84 37.27 2 A ILE 59 60.99 -65.92 2 A LYS 77 -80.36 -155.20 2 A ASP 78 68.05 119.15 2 A ARG 79 -170.42 -40.84 2 A ALA 83 -143.49 41.59 2 A ALA 86 -165.83 105.06 2 A MET 94 -81.81 -93.20 2 A SER 95 -151.17 -45.74 2 A ASP 96 -89.68 33.25 2 A ASP 109 69.60 145.49 2 A TYR 110 -84.23 42.03 2 A ASN 111 -80.18 -114.60 2 A TRP 112 -153.49 37.97 2 A LYS 123 -82.18 46.84 2 A ARG 126 72.39 123.14 2 A ASP 129 -157.18 -153.93 2 A ASN 139 -88.55 44.83 2 A SER 141 -154.65 62.84 2 A ASN 147 -51.50 97.37 2 A SER 166 -85.07 -131.38 2 A SER 167 62.59 -145.52 3 A VAL 4 61.07 61.46 3 A ALA 12 -162.54 -28.07 3 A LEU 26 -80.23 48.40 3 A SER 54 -110.34 -78.87 3 A SER 57 -166.27 -58.85 3 A HIS 63 -177.98 -50.83 3 A PRO 66 -77.35 -119.27 3 A ARG 79 72.53 145.54 3 A ALA 86 -165.72 119.91 3 A SER 95 -163.09 -101.94 3 A TYR 108 -93.49 42.43 3 A ASN 111 -132.12 -130.93 3 A LYS 125 69.24 -46.22 3 A TYR 133 -131.29 -41.76 3 A GLU 135 -140.05 -58.65 3 A TYR 138 -82.18 47.86 3 A ASN 139 -147.84 -38.43 3 A SER 141 -151.86 61.52 3 A PHE 143 -73.25 -111.43 3 A ARG 144 -170.33 -4.75 3 A ASN 147 -53.25 88.93 3 A SER 166 -98.63 -119.63 3 A SER 167 70.83 -45.57 4 A ASP 3 66.06 124.72 4 A ALA 7 67.34 141.43 4 A ALA 12 -151.54 -27.00 4 A SER 57 -135.75 -85.97 4 A ARG 79 50.54 -84.45 4 A SER 95 176.53 -129.83 4 A PRO 107 -67.49 -147.99 4 A ASP 109 54.66 144.73 4 A TYR 110 -80.76 43.60 4 A TRP 112 -160.57 48.36 4 A ASP 129 -169.35 -138.55 4 A TYR 133 -69.43 -178.72 4 A GLU 135 -175.32 -50.84 4 A TYR 137 -67.61 -161.42 4 A LEU 140 -89.60 43.97 4 A SER 141 -177.42 41.88 4 A ASN 147 -49.47 90.95 4 A PHE 163 -170.76 -142.22 4 A SER 166 -101.55 -119.57 4 A SER 167 71.55 -47.51 5 A ALA 2 70.81 -56.27 5 A VAL 4 71.52 -53.54 5 A ALA 7 62.98 118.56 5 A ALA 12 -159.67 -36.97 5 A VAL 29 -89.69 -159.57 5 A LYS 30 -79.56 -146.28 5 A SER 41 -130.54 -30.86 5 A SER 54 -131.21 -82.25 5 A HIS 63 -92.64 47.10 5 A LYS 77 -120.02 -155.77 5 A MET 94 -85.95 -86.11 5 A SER 95 -154.20 -42.77 5 A ASP 96 -89.19 31.31 5 A TYR 108 -98.90 37.45 5 A ASN 111 -168.94 -123.53 5 A TRP 112 -105.15 42.77 5 A LYS 125 71.41 -39.10 5 A ASP 129 -137.27 -151.56 5 A GLU 134 -100.52 -139.46 5 A GLU 135 59.40 -107.84 5 A TYR 137 -73.52 48.96 5 A SER 141 -153.85 65.26 5 A ASN 147 -51.24 93.92 5 A SER 166 -105.42 -125.16 5 A SER 167 70.75 -48.11 6 A ALA 2 69.66 143.30 6 A VAL 4 -82.68 46.18 6 A GLU 40 -141.87 39.73 6 A SER 54 -101.77 -99.79 6 A SER 57 -131.06 -62.64 6 A ASP 58 -174.76 37.81 6 A ILE 59 53.50 -52.59 6 A PRO 81 -75.39 41.90 6 A SER 95 -177.27 -55.10 6 A ASP 96 -89.41 38.95 6 A TYR 108 -102.91 41.73 6 A ASP 109 -128.27 -134.40 6 A ASN 111 -71.75 43.31 6 A ARG 126 -131.86 -35.97 6 A ASP 129 -150.68 -124.17 6 A TYR 138 -91.71 46.60 6 A ASN 139 -133.52 -44.40 6 A SER 141 -168.13 56.75 6 A ASN 147 -56.63 -9.20 6 A ARG 152 179.78 148.81 6 A SER 166 -97.45 -112.02 6 A SER 167 64.59 -54.32 6 A GLU 173 -116.75 63.75 7 A ALA 2 71.05 -58.79 7 A ALA 7 72.24 134.65 7 A ALA 12 -160.27 -28.98 7 A ASN 28 -66.95 90.54 7 A LYS 32 -176.64 142.49 7 A SER 41 -141.88 -31.62 7 A ASN 49 -176.28 149.71 7 A SER 54 -80.85 -86.34 7 A SER 57 -167.90 -51.16 7 A ARG 79 -146.90 -47.50 7 A ALA 83 -80.47 -152.50 7 A THR 84 52.79 115.89 7 A SER 95 -164.55 -70.74 7 A ASP 96 -89.33 48.18 7 A PRO 107 -77.30 -169.92 7 A LYS 125 -137.12 -47.68 7 A ARG 126 61.52 101.68 7 A ARG 127 70.56 125.11 7 A TYR 133 -107.49 43.20 7 A GLU 135 -146.54 42.77 7 A TYR 137 -173.36 -49.58 7 A TYR 138 -161.73 43.85 7 A SER 141 -167.82 68.35 7 A ASN 147 -28.86 94.20 7 A TRP 149 -174.48 143.84 7 A TYR 156 -91.61 47.83 7 A PHE 163 -173.24 -141.94 7 A SER 166 -99.80 -127.93 7 A GLU 173 -116.24 64.17 7 A THR 177 -145.85 -154.91 8 A ASP 3 68.86 125.93 8 A ALA 12 -156.65 -30.37 8 A GLU 40 -141.12 43.67 8 A SER 54 -142.55 -63.76 8 A ASP 58 -174.84 144.20 8 A HIS 63 -94.38 38.90 8 A GLN 76 -120.91 -139.69 8 A ARG 79 66.34 148.29 8 A ALA 86 -165.55 116.06 8 A SER 95 -171.31 -51.69 8 A ASP 109 54.67 -44.54 8 A TYR 122 -125.75 -164.02 8 A ARG 126 70.86 137.98 8 A ASP 129 -158.19 -154.08 8 A GLU 135 -90.09 -139.04 8 A SER 141 -158.24 61.95 8 A ASN 147 -39.88 93.65 8 A SER 166 -98.69 -125.41 8 A GLU 173 -112.88 62.35 9 A ASP 3 66.93 -44.89 9 A ALA 5 64.50 141.72 9 A ALA 7 67.12 117.04 9 A ASP 10 -79.10 29.94 9 A LEU 26 -82.29 48.05 9 A ASN 28 -164.23 -44.25 9 A ASP 58 -175.27 38.58 9 A ILE 59 53.19 -53.30 9 A ASN 74 -161.64 115.66 9 A SER 95 -156.30 -69.81 9 A TRP 112 -69.84 56.36 9 A LYS 125 -82.94 -125.39 9 A ARG 126 -149.58 -49.71 9 A ASP 129 176.05 -147.60 9 A GLU 135 74.31 -51.09 9 A TYR 137 -77.03 37.10 9 A TYR 138 -146.88 32.95 9 A ASN 139 -143.28 -43.48 9 A SER 141 -173.95 70.51 9 A ASP 146 -171.48 126.02 9 A ASN 147 -66.14 3.57 9 A TRP 149 -170.97 131.58 9 A LEU 154 -158.94 -28.75 9 A PHE 163 -168.12 -166.99 9 A SER 166 -82.78 -133.24 9 A SER 167 61.94 -149.04 10 A ASP 3 69.68 -46.55 10 A VAL 4 50.98 -152.85 10 A ALA 5 67.94 -64.35 10 A ALA 12 -165.83 -24.18 10 A ASN 28 -79.23 47.61 10 A LYS 30 -63.99 -71.76 10 A LEU 48 -100.43 -61.90 10 A ASN 49 -176.37 146.53 10 A SER 54 -91.02 -97.95 10 A SER 57 -170.32 -146.00 10 A HIS 63 -179.99 -53.66 10 A ASP 78 -163.62 -136.86 10 A THR 84 58.37 165.58 10 A ALA 86 -172.26 128.77 10 A SER 95 -169.26 -51.81 10 A TYR 108 -95.21 47.98 10 A ASP 109 66.40 104.89 10 A TRP 112 -145.32 50.04 10 A ASN 118 -164.50 116.00 10 A LYS 123 -79.82 44.60 10 A LYS 125 72.28 -40.95 10 A ASP 129 -161.05 -160.36 10 A GLU 135 69.87 -68.45 10 A TYR 138 -167.91 -45.19 10 A SER 141 -158.41 64.78 10 A ASN 147 -58.14 89.33 10 A PHE 163 -172.09 -162.33 10 A SER 166 -80.95 -127.11 10 A SER 167 63.10 -151.92 11 A VAL 4 69.73 -57.77 11 A ALA 5 68.31 140.59 11 A ALA 7 -83.40 41.85 11 A ALA 12 -156.84 -29.11 11 A LEU 26 -83.59 47.64 11 A SER 41 -145.83 -10.12 11 A SER 54 -129.49 -80.26 11 A ASP 58 -165.34 37.78 11 A ILE 59 58.27 -47.62 11 A PRO 66 -91.13 -126.06 11 A LYS 77 -83.16 -141.97 11 A ASP 78 71.54 142.09 11 A ARG 79 -171.42 -42.14 11 A MET 94 -85.61 -92.16 11 A SER 95 -150.71 -40.95 11 A ASP 96 -89.62 32.95 11 A TYR 108 -86.47 43.27 11 A TYR 110 -117.93 58.63 11 A ASN 111 -149.75 -123.84 11 A TRP 112 -75.62 48.55 11 A ASP 129 -126.02 -160.39 11 A GLU 134 -88.30 43.38 11 A GLU 135 -94.31 -134.18 11 A ASN 139 -90.42 48.27 11 A SER 141 -167.63 66.74 11 A ASN 147 -37.34 99.04 11 A TRP 149 -173.09 139.44 11 A SER 166 -105.99 -130.29 11 A SER 167 70.61 -42.60 12 A ALA 2 67.87 -62.96 12 A VAL 4 73.52 129.71 12 A ALA 12 -173.77 43.76 12 A SER 13 -144.97 -39.81 12 A LEU 26 -81.52 37.39 12 A SER 41 -166.44 -24.16 12 A SER 54 -134.96 -57.05 12 A SER 57 -148.84 -76.84 12 A ASP 58 -166.25 40.57 12 A ILE 59 49.73 -65.47 12 A PRO 62 -41.71 157.58 12 A HIS 63 -73.80 -110.89 12 A SER 95 -150.90 -69.88 12 A ASP 109 -147.94 -136.94 12 A ASN 111 -70.76 40.51 12 A LYS 125 -75.28 44.44 12 A TYR 137 -81.90 -98.96 12 A TYR 138 -172.19 120.91 12 A ASN 139 -147.06 -34.63 12 A SER 141 -166.10 64.44 12 A ASN 147 -49.25 97.31 12 A TRP 149 -179.14 135.35 12 A SER 166 -104.25 -135.23 12 A GLU 173 -107.12 51.63 13 A ALA 12 -150.69 -46.82 13 A ASN 28 -66.57 98.80 13 A SER 54 -151.92 -63.27 13 A SER 57 -164.17 -80.30 13 A HIS 63 -66.53 -143.87 13 A ARG 79 -155.47 -50.32 13 A THR 84 -152.41 -47.50 13 A SER 95 -155.70 -55.06 13 A TYR 108 -90.47 -139.72 13 A ASP 109 -97.37 43.41 13 A LYS 123 -95.99 48.76 13 A LYS 125 71.99 -46.24 13 A ASP 129 -146.57 -155.79 13 A GLU 134 -85.73 48.43 13 A GLU 135 -81.47 -122.62 13 A TYR 137 -176.53 -50.28 13 A ASN 139 -133.24 -49.75 13 A SER 141 -160.72 65.62 13 A ASN 147 -44.61 95.52 13 A TRP 149 -173.59 121.09 13 A PHE 163 -174.52 149.87 13 A SER 166 -96.98 -131.39 13 A GLU 173 -108.46 58.16 14 A ALA 2 -84.94 45.24 14 A VAL 8 -144.74 58.78 14 A ALA 12 -157.33 -31.04 14 A LEU 26 -82.32 38.32 14 A ASN 49 -172.43 147.82 14 A SER 54 -98.00 -100.60 14 A THR 56 -171.29 149.68 14 A ASP 58 -171.51 148.02 14 A THR 84 -130.48 -47.86 14 A SER 95 -163.18 -74.42 14 A ASP 129 -162.78 -161.09 14 A GLU 134 -94.70 32.68 14 A LEU 136 -89.68 -96.45 14 A TYR 137 -162.34 -58.94 14 A TYR 138 -89.02 44.11 14 A ASN 147 -0.21 88.14 14 A PHE 163 177.30 167.28 14 A ALA 170 -170.76 -129.76 14 A LEU 172 -161.84 112.20 14 A THR 177 -144.06 -155.65 15 A ALA 2 67.86 128.75 15 A VAL 4 -130.48 -55.92 15 A ALA 5 68.66 144.40 15 A ILE 9 -104.15 -150.59 15 A ALA 12 -150.52 -29.62 15 A LEU 26 -59.69 -70.62 15 A SER 41 -142.34 -22.78 15 A THR 46 -118.50 -110.52 15 A ASN 49 -173.23 144.72 15 A SER 54 -102.94 -111.78 15 A HIS 63 -108.07 57.51 15 A LYS 64 -164.10 117.50 15 A PRO 66 -81.72 -135.04 15 A ASP 78 -167.23 107.35 15 A ARG 79 -156.77 -63.51 15 A PRO 81 -67.68 -136.64 15 A SER 95 -172.71 -93.14 15 A ASP 109 69.74 -49.77 15 A LYS 125 -172.15 -39.68 15 A ASP 129 -160.56 -157.64 15 A TYR 138 -85.69 39.04 15 A SER 141 -175.13 68.61 15 A ARG 144 73.70 -6.14 15 A ASP 146 -171.59 137.51 15 A ASN 147 -45.66 94.96 15 A SER 166 -81.82 -122.14 15 A SER 167 65.74 -151.48 16 A ALA 2 -94.86 47.54 16 A VAL 4 72.01 -47.13 16 A ALA 5 -151.00 -41.26 16 A ALA 12 -160.15 -30.93 16 A GLU 40 -117.69 67.58 16 A SER 54 -104.43 -90.15 16 A THR 56 -170.33 147.22 16 A HIS 63 -77.05 48.36 16 A LYS 64 -171.36 123.55 16 A PRO 66 -82.81 -144.67 16 A ARG 79 -142.46 -62.39 16 A ALA 83 -77.49 39.30 16 A ALA 86 -164.22 114.26 16 A SER 95 -171.29 -72.11 16 A ASP 109 71.88 148.16 16 A ASN 111 -162.47 -142.43 16 A TRP 112 -93.55 41.19 16 A LYS 123 -92.89 46.96 16 A LYS 125 68.87 -47.04 16 A TYR 133 -77.46 -127.46 16 A GLU 135 -172.35 -106.02 16 A TYR 137 -76.67 44.50 16 A TYR 138 -111.72 -110.89 16 A LEU 140 -152.24 -144.17 16 A ASN 147 -49.03 96.82 16 A TRP 149 -171.50 125.68 16 A SER 166 -81.74 -124.23 16 A SER 167 67.74 -148.33 16 A GLU 173 -113.10 76.92 17 A ASP 3 65.19 135.41 17 A ALA 5 -151.76 36.70 17 A ALA 12 -131.92 -46.66 17 A SER 13 -83.27 44.54 17 A ASN 28 -100.37 -93.48 17 A LEU 48 -121.93 -50.31 17 A SER 54 -121.23 -76.76 17 A SER 57 -109.59 -67.50 17 A ASP 58 -172.47 37.11 17 A ILE 59 65.05 -57.34 17 A PRO 62 -48.28 -77.96 17 A HIS 63 -175.07 -58.93 17 A ARG 79 66.60 137.55 17 A SER 95 -168.89 -48.33 17 A ASP 96 -89.41 32.34 17 A ASP 109 59.48 -38.82 17 A LYS 125 48.27 -153.80 17 A ARG 126 69.89 137.92 17 A MET 132 -90.96 -62.26 17 A TYR 133 -153.00 36.36 17 A GLU 134 -102.55 60.56 17 A GLU 135 -77.38 -144.22 17 A TYR 137 -162.52 -46.50 17 A ASN 139 -149.52 -49.92 17 A ARG 144 73.00 -10.60 17 A ASN 147 -54.34 91.10 17 A ARG 152 -175.69 140.32 17 A LEU 154 -154.67 -26.39 17 A PHE 163 179.56 177.17 17 A SER 166 -91.76 -124.60 17 A GLU 173 -114.42 57.42 17 A THR 177 -141.66 -159.51 18 A ALA 2 67.24 119.86 18 A VAL 4 -79.85 45.62 18 A ALA 7 -158.56 46.48 18 A ALA 12 -157.58 -37.26 18 A LEU 26 -95.86 32.30 18 A SER 41 -151.94 -31.10 18 A THR 46 -108.26 -104.99 18 A ALA 47 -172.84 118.05 18 A SER 54 -125.89 -63.04 18 A SER 57 -159.03 -159.85 18 A ASP 58 -83.81 44.81 18 A ILE 59 55.35 -54.11 18 A PRO 66 -82.05 -156.91 18 A ARG 79 -168.45 -39.99 18 A THR 84 -157.99 -54.44 18 A SER 95 -171.90 -74.48 18 A ASP 96 -88.90 46.85 18 A ASP 109 -145.07 -141.79 18 A ARG 127 74.21 128.67 18 A ASP 129 -154.71 -146.92 18 A TYR 133 -143.26 25.99 18 A GLU 134 -99.91 54.94 18 A GLU 135 -144.94 -56.55 18 A TYR 138 -86.06 45.94 18 A ASN 139 -125.63 -56.75 18 A SER 141 -152.91 68.54 18 A ASN 147 -45.89 96.18 18 A TYR 156 -83.73 42.15 18 A SER 166 -171.82 121.72 18 A GLU 173 -118.55 77.41 19 A ALA 2 -163.80 -50.69 19 A ALA 7 68.79 125.24 19 A ALA 12 -143.58 -27.26 19 A LEU 26 -83.24 46.70 19 A LYS 30 -83.45 40.31 19 A ARG 31 -169.35 85.14 19 A SER 41 -142.40 -80.80 19 A THR 46 -122.13 -120.18 19 A ASN 49 -177.97 148.02 19 A SER 54 -145.85 -78.45 19 A SER 57 -124.09 -53.55 19 A HIS 63 -93.60 44.08 19 A LYS 64 -161.64 113.67 19 A PRO 66 -78.50 -119.80 19 A GLN 76 -116.01 -138.78 19 A ARG 79 72.04 131.63 19 A SER 95 -169.53 -62.27 19 A ASP 109 70.30 -71.49 19 A ARG 127 71.47 125.84 19 A ASP 129 -163.91 -154.19 19 A GLU 135 -159.78 -70.93 19 A TYR 138 -164.42 -25.98 19 A SER 141 -175.36 67.87 19 A ASN 147 -52.28 94.90 19 A TRP 149 -171.65 132.52 19 A PHE 163 -175.86 146.38 19 A SER 166 -88.97 -123.85 19 A SER 167 71.71 48.41 20 A ALA 5 -158.02 -44.82 20 A ALA 7 -142.07 50.00 20 A ALA 12 -168.35 -33.61 20 A ASN 28 -87.41 39.34 20 A THR 46 -89.21 -130.86 20 A SER 54 -143.84 -79.00 20 A SER 57 -157.33 -52.64 20 A PRO 62 -59.19 -106.21 20 A HIS 63 -154.56 -48.36 20 A PRO 66 -75.71 -156.93 20 A ARG 79 -167.87 -28.33 20 A PRO 81 -74.86 -135.79 20 A MET 94 -92.33 -60.83 20 A SER 95 -171.07 -61.73 20 A ASP 96 -89.05 43.79 20 A TYR 108 -82.98 40.26 20 A ASN 111 -141.26 -129.51 20 A TYR 133 -136.16 -37.13 20 A GLU 135 73.48 -46.51 20 A ASN 147 -47.14 93.36 20 A SER 166 0.72 75.09 20 A SER 167 -7.84 -51.52 20 A ALA 170 -163.25 -140.38 20 A GLU 173 -94.31 57.24 Solution structure of the eukaryotic pore-forming cytolysin equinatoxin II 1 N N A SER 15 A SER 15 HELX_P A ALA 25 A ALA 25 1 1 11 A ASP 129 A ASP 129 HELX_P A GLU 134 A GLU 134 1 2 6 MEMBRANE PROTEIN cytolysin, pore formation, beta sandwich, toxin, sea anemone, MEMBRANE PROTEIN EQT2_ACTEQ UNP 1 36 P61914 SADVAGAVIDGASLSFDILKTVLEALGNVKRKIAVGVDNESGKTWTALNTYFRSGTSDIVLPHKVPHGKALLYNGQKDRG PVATGAVGVLAYLMSDGNTLAVLFSVPYDYNWYSNWWNVRIYKGKRRADQRMYEELYYNLSPFRGDNGWHTRNLGYGLKS RGFMNSSGHAILEIHVSKA 36 214 1KD6 1 179 P61914 A 1 1 179 1 SER SEE REMARK 999 THR 177 1KD6 A P61914 UNP 212 177 5 5 anti-parallel parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A LYS 69 A LYS 69 A GLY 75 A GLY 75 A ILE 33 A ILE 33 A ASN 39 A ASN 39 A ALA 170 A ALA 170 A THR 177 A THR 177 A LYS 159 A LYS 159 A ASN 165 A ASN 165 A HIS 150 A HIS 150 A ASN 153 A ASN 153 A THR 46 A THR 46 A PHE 52 A PHE 52 A GLY 88 A GLY 88 A LEU 93 A LEU 93 A ASN 98 A ASN 98 A SER 105 A SER 105 A TRP 116 A TRP 116 A LYS 123 A LYS 123 A PHE 143 A PHE 143 A ARG 144 A ARG 144